Is Boston Scientific Corporation (BSX) A Good Stock To Buy Now?

robot
Abstract generation in progress

This article analyzes a bullish thesis on Boston Scientific Corporation (BSX), highlighting its strong organic growth, multiple product catalysts like FARAPULSE and WATCHMAN, and strategic acquisitions despite recent short-term setbacks. The company is considered undervalued compared to peers, with a projected 71% upside driven by re-rating and integration benefits, making it a strong buy across various time horizons. However, the article also notes BSX is not on their list of most popular hedge fund stocks and suggests other AI stocks might offer greater returns.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin